In an attempt to integrate protein biomarkers and ctDNA in PDAC detection, Cohen et al. [78] presented a study incorporating the data from KRAS ctDNA sequencing and four additional protein markers (CA19–9, CEA, HGF and OPN) and reported an increased specificity and sensitivity in early stage pancreatic cancer detection. This evidence concerns the gene KRAS and pancreatic neoplasm.